Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Brullo

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Future Medicinal Chemistry|April 26, 2012
An update on dual Src/Abl inhibitorsFrancesca Musumeci, Silvia Schenone, Chiara Brullo, et al.
European Journal of Medicinal Chemistry|December 14, 2011
N-Aryl-2-phenyl-2,3-dihydro-imidazo[1,2-b]pyrazole-1-carboxamides 7-substituted strongly inhibiting both fMLP-OMe- and IL-8-induced human neutrophil chemotaxisChiara Brullo, Susanna Spisani, Rita Selvatici, et al.
Nanomaterials (Basel, Switzerland)|April 12, 2022
Synthesis and Characterization of Pyrazole-Enriched Cationic Nanoparticles as New Promising Antibacterial Agent by Mutual CooperationSilvana Alfei, Guendalina Zuccari, Debora Caviglia, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Nanotechnology for Pediatric Retinoblastoma TherapyEleonora Russo, Andrea Spallarossa, Bruno Tasso, et al.
International Journal of Molecular Sciences|January 21, 2023
Hydrogel Formulations of Antibacterial Pyrazoles Using a Synthesized Polystyrene-Based Cationic Resin as a Gelling AgentSilvana Alfei, Guendalina Zuccari, Eleonora Russo, et al.
International Journal of Molecular Sciences|June 24, 2022
The Development of FAK Inhibitors: A Five-Year UpdateAndrea Spallarossa, Bruno Tasso, Eleonora Russo, et al.
Expert Opinion on Therapeutic Patents|September 16, 2015
Analogs, formulations and derivatives of imatinib: a patent reviewFrancesca Musumeci, Silvia Schenone, Giancarlo Grossi, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Pyrazole-Enriched Cationic Nanoparticles Induced Early- and Late-Stage Apoptosis in Neuroblastoma Cells at Sub-Micromolar ConcentrationsGuendalina Zuccari, Alessia Zorzoli, Danilo Marimpietri, et al.
Expert Opinion on Therapeutic Patents|February 7, 2015
Bcr-Abl tyrosine kinase inhibitors: a patent reviewAndrea Desogus, Silvia Schenone, Chiara Brullo, et al.
Molecular Diversity|July 22, 2022
Mono- and di-acylated imidazolidine-2-thione derivatives: synthesis, cytotoxicity evaluation and computational studiesAnna Scarsi, Marco Ponassi, Chiara Brullo, et al.
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Future Medicinal Chemistry|April 26, 2012
An update on dual Src/Abl inhibitorsFrancesca Musumeci, Silvia Schenone, Chiara Brullo, et al.
European Journal of Medicinal Chemistry|December 14, 2011
N-Aryl-2-phenyl-2,3-dihydro-imidazo[1,2-b]pyrazole-1-carboxamides 7-substituted strongly inhibiting both fMLP-OMe- and IL-8-induced human neutrophil chemotaxisChiara Brullo, Susanna Spisani, Rita Selvatici, et al.
Nanomaterials (Basel, Switzerland)|April 12, 2022
Synthesis and Characterization of Pyrazole-Enriched Cationic Nanoparticles as New Promising Antibacterial Agent by Mutual CooperationSilvana Alfei, Guendalina Zuccari, Debora Caviglia, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
Nanotechnology for Pediatric Retinoblastoma TherapyEleonora Russo, Andrea Spallarossa, Bruno Tasso, et al.
International Journal of Molecular Sciences|January 21, 2023
Hydrogel Formulations of Antibacterial Pyrazoles Using a Synthesized Polystyrene-Based Cationic Resin as a Gelling AgentSilvana Alfei, Guendalina Zuccari, Eleonora Russo, et al.
International Journal of Molecular Sciences|June 24, 2022
The Development of FAK Inhibitors: A Five-Year UpdateAndrea Spallarossa, Bruno Tasso, Eleonora Russo, et al.
Expert Opinion on Therapeutic Patents|September 16, 2015
Analogs, formulations and derivatives of imatinib: a patent reviewFrancesca Musumeci, Silvia Schenone, Giancarlo Grossi, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Pyrazole-Enriched Cationic Nanoparticles Induced Early- and Late-Stage Apoptosis in Neuroblastoma Cells at Sub-Micromolar ConcentrationsGuendalina Zuccari, Alessia Zorzoli, Danilo Marimpietri, et al.
Expert Opinion on Therapeutic Patents|February 7, 2015
Bcr-Abl tyrosine kinase inhibitors: a patent reviewAndrea Desogus, Silvia Schenone, Chiara Brullo, et al.
Molecular Diversity|July 22, 2022
Mono- and di-acylated imidazolidine-2-thione derivatives: synthesis, cytotoxicity evaluation and computational studiesAnna Scarsi, Marco Ponassi, Chiara Brullo, et al.
Pageof 11